This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Latest news, analysis and insight in fastest growing sector in agriculture.

Botanical Solution Inc. secures $6.1 million in Series A First Closing

Share this article

U.S.-based Botanical Solution Inc. (BSI) successfully closed USD$6.1 million in a Series A round led by Palo Alto, California-based VC Firm, Otter Capital.

This Series A round of funding will support the production and sales growth of BSI’s first commercially successful product marketed as BotriStop and its recently announced global brand Quillibrium, which are based on a tissue cultured tree native to Chile, the Quillaja saponaria. The product has been used successfully on a wide variety of fruits and vegetables throughout Chile.

Quillibrium was launched in Peru last year and will soon reach growers across Mexico through BSI’s main distribution partner Syngenta. Meanwhile, Quillibrium continues the regulatory progress in the U.S. and will soon initiate registration in additional countries.

This new funding will also accelerate market readiness of new botanical biopesticide products currently in later development stages and enable the expansion of BSI’s R&D pipeline.

Two long-time investors joining Otter Capital in this First Closing of the Series A are Inversiones el Coigue and Inversiones Eurocel, both based in Santiago, Chile.

Read about BSI’s expansion plans in New AG International here.

Share this article